LANVIS
Identification of Lanvis
| No description |
Google image searchProduct monograph
Active ingredient
thioguanine, 40 MG
DIN: 00282081
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ASPEN PHARMACARE CANADA INC.
Date: 10-JUL-2020
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BB — Purine analogues (ATC, ATC/DDD)
- L01BB03 — TIOGUANINE (ATC/DDD)
Reference brand drug: Lanvis
Pharmaceutical standard: USP
